Leroith D - Search Results

1

Absence of the full-length breast cancer-associated gene-1 leads to increased expression of insulin-like growth factor signaling axis members.

Shukla V, Coumoul X, Cao L, Wang RH, Xiao C, Xu X, Andò S, Yakar S, Leroith D, Deng C. Shukla V, et al. Among authors: leroith d. Cancer Res. 2006 Jul 15;66(14):7151-7. doi: 10.1158/0008-5472.CAN-05-4570. Cancer Res. 2006. PMID: 16849561

2

Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.

Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S. Wu Y, et al. Among authors: leroith d. Cancer Res. 2003 Aug 1;63(15):4384-8. Cancer Res. 2003. PMID: 12907608

3

Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.

Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Wu Y, et al. Among authors: leroith d. Cancer Res. 2002 Feb 15;62(4):1030-5. Cancer Res. 2002. PMID: 11861378

4

TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival.

Toyoshima Y, Karas M, Yakar S, Dupont J, Lee Helman, LeRoith D. Toyoshima Y, et al. Among authors: leroith d. J Biol Chem. 2004 Jun 11;279(24):25898-904. doi: 10.1074/jbc.M400661200. Epub 2004 Mar 22. J Biol Chem. 2004. PMID: 15037619 Free article.

5

14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation.

Zhang Y, Karas M, Zhao H, Yakar S, LeRoith D. Zhang Y, et al. Among authors: leroith d. J Biol Chem. 2004 Aug 13;279(33):34353-60. doi: 10.1074/jbc.M401300200. Epub 2004 Jun 8. J Biol Chem. 2004. PMID: 15187095 Free article.

6

Role of growth hormone (GH) in liver regeneration.

Pennisi PA, Kopchick JJ, Thorgeirsson S, LeRoith D, Yakar S. Pennisi PA, et al. Among authors: leroith d. Endocrinology. 2004 Oct;145(10):4748-55. doi: 10.1210/en.2004-0655. Epub 2004 Jul 8. Endocrinology. 2004. PMID: 15242989

7

Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse.

Yakar S, Pennisi P, Zhao H, Zhang Y, LeRoith D. Yakar S, et al. Among authors: leroith d. Novartis Found Symp. 2004;262:3-9; discussion 9-18, 265-8. Novartis Found Symp. 2004. PMID: 15562820 Review.

8

Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo.

Kim H, Barton E, Muja N, Yakar S, Pennisi P, Leroith D. Kim H, et al. Among authors: leroith d. Endocrinology. 2005 Apr;146(4):1772-9. doi: 10.1210/en.2004-0906. Epub 2004 Dec 23. Endocrinology. 2005. PMID: 15618350

9

The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting.

Yakar S, Kim H, Zhao H, Toyoshima Y, Pennisi P, Gavrilova O, Leroith D. Yakar S, et al. Among authors: leroith d. Pediatr Nephrol. 2005 Mar;20(3):251-4. doi: 10.1007/s00467-004-1613-y. Epub 2005 Jan 12. Pediatr Nephrol. 2005. PMID: 15645308 Review.

10

Clinical relevance of systemic and local IGF-I.

Yakar S, Pennisi P, Wu Y, Zhao H, LeRoith D. Yakar S, et al. Among authors: leroith d. Endocr Dev. 2005;9:11-16. doi: 10.1159/000085718. Endocr Dev. 2005. PMID: 15879684 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

689 results

Search Page

Filters